Search research articles
Contact Us
Filters
Showing results (201-210 of 310) with videos related to
Page
of 31
Sort By:
Clinical Science (London, England : 1979)
|
May 1, 1980
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man
G A Fitzgerald, C A Hamilton, D H Jones, et al.
The Journal of Clinical Investigation
|
October 1, 1983
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man
G A FitzGerald, A R Brash, J A Oates, et al.
Circulation
|
July 1, 1990
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo
G A Braden, H R Knapp, D J Fitzgerald, et al.
British Journal of Clinical Pharmacology
|
March 1, 1980
No evidence for antagonism of clonidine by naloxone in man [proceedings]
M J Brown, C T Dollery, G A Fitzgerald, et al.
Analytical Biochemistry
|
September 15, 1998
Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry
M Adiyaman, J A Lawson, S P Khanapure, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 16, 1998
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress
D Praticò, S Basili, M Vieri, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1987
Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets
D J Fitzgerald, G Mayo, F Catella, et al.
Blood
|
April 27, 1999
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients
D Ferro, S Basili, D Praticó, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
December 23, 1998
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients
D Praticò, E Rossi, M Merli, et al.
Nature Medicine
|
October 15, 1998
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
D Praticò, R K Tangirala, D J Rader, et al.
Page
of 31
Search research articles
Search
Showing results (201-210 of 310) with videos related to
Sort By:
Page
of 31
Clinical Science (London, England : 1979)
|
May 1, 1980
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man
G A Fitzgerald, C A Hamilton, D H Jones, et al.
The Journal of Clinical Investigation
|
October 1, 1983
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man
G A FitzGerald, A R Brash, J A Oates, et al.
Circulation
|
July 1, 1990
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo
G A Braden, H R Knapp, D J Fitzgerald, et al.
British Journal of Clinical Pharmacology
|
March 1, 1980
No evidence for antagonism of clonidine by naloxone in man [proceedings]
M J Brown, C T Dollery, G A Fitzgerald, et al.
Analytical Biochemistry
|
September 15, 1998
Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry
M Adiyaman, J A Lawson, S P Khanapure, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 16, 1998
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress
D Praticò, S Basili, M Vieri, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1987
Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets
D J Fitzgerald, G Mayo, F Catella, et al.
Blood
|
April 27, 1999
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients
D Ferro, S Basili, D Praticó, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
December 23, 1998
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients
D Praticò, E Rossi, M Merli, et al.
Nature Medicine
|
October 15, 1998
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
D Praticò, R K Tangirala, D J Rader, et al.
Page
of 31